<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "JATS-journalpublishing1-4.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.4" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ojbd</journal-id>
      <journal-title-group>
        <journal-title>Open Journal of Blood Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2164-3199</issn>
      <issn pub-type="ppub">2164-3180</issn>
      <publisher>
        <publisher-name>Scientific Research Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.4236/ojbd.2026.161007</article-id>
      <article-id pub-id-type="publisher-id">ojbd-150347</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
        <subj-group>
          <subject>Medicine</subject>
          <subject>Healthcare</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sickle Cell Disease in Children at Agadez (Niger): Epidemiology, Diagnosis and Management</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Djibrilla-Almoustapha</surname>
            <given-names>Amadou</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malam-Abdou</surname>
            <given-names>Badé</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Garo</surname>
            <given-names>Samira Abdou-Yazi</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ibrahim-Moumouni</surname>
            <given-names>Hamed Dourfaye</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Elhadji-Chefou</surname>
            <given-names>Moustapha</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Maman-Brah</surname>
            <given-names>Moustapha</given-names>
          </name>
          <xref ref-type="aff" rid="aff5">5</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adamou-Chaibou</surname>
            <given-names>Oumarou</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ousseini</surname>
            <given-names>Fanta</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boureima</surname>
            <given-names>Mariama</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mahamadou</surname>
            <given-names>Safia</given-names>
          </name>
          <xref ref-type="aff" rid="aff6">6</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sidi-Halidou</surname>
            <given-names>Adamou</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Adika-Konaté</surname>
            <given-names>Samira</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Saidou-Sabo</surname>
            <given-names>Malika</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nouhou-Tanda</surname>
            <given-names>Nadia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moumouni-Sina</surname>
            <given-names>Abdramane</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Moustapha-Ali</surname>
            <given-names>Mahaman Saifou</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Hematology Department of National Hospital of Niamey, Niamey, Niger </aff>
      <aff id="aff2"><label>2</label> Faculty of Health Sciences, Abdou Moumouni University of Niamey, Niamey, Niger </aff>
      <aff id="aff3"><label>3</label> Mother and Child Health Center (CSME) of Agadez, Agadez, Niger </aff>
      <aff id="aff4"><label>4</label> Maradi Referral Hospital, Dan Dicko Dankoulodo University of Maradi, Maradi, Niger </aff>
      <aff id="aff5"><label>5</label> National Hospital of Zinder, André Salifou University of Zinder, Zinder, Niger </aff>
      <aff id="aff6"><label>6</label> Sickle Cell Disease Reference Center (CNRD), Niamey, Niger </aff>
      <author-notes>
        <fn fn-type="conflict" id="fn-conflict">
          <p>The authors declare no conflicts of interest regarding the publication of this paper.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>03</month>
        <year>2026</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>03</month>
        <year>2026</year>
      </pub-date>
      <volume>16</volume>
      <issue>01</issue>
      <fpage>48</fpage>
      <lpage>55</lpage>
      <history>
        <date date-type="received">
          <day>04</day>
          <month>01</month>
          <year>2026</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>03</month>
          <year>2026</year>
        </date>
        <date date-type="published">
          <day>23</day>
          <month>03</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2026 by the authors and Scientific Research Publishing Inc.</copyright-statement>
        <copyright-year>2026</copyright-year>
        <license license-type="open-access">
          <license-p> This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link> ). </license-p>
        </license>
      </permissions>
      <self-uri content-type="doi" xlink:href="https://doi.org/10.4236/ojbd.2026.161007">https://doi.org/10.4236/ojbd.2026.161007</self-uri>
      <abstract>
        <p><bold>Objective:</bold>To determine the epidemiological, diagnostic, and therapeutic aspects of major sickle cell syndromes followed at the Agadez Mother and Child Health Center. <bold>Materials</bold><bold>and</bold><bold>Methods</bold><bold>:</bold> This was a prospective, descriptive, and analytical study including all sickle cell patients, regardless of age or sex, registered from February 1, 2025, to July 31, 2025. <bold>Results:</bold> 150 cases of sickle cell disease were recorded out of 2578 patients, representing a frequency of 5.81%. The majority of patients were between 24 and 60 months old (34%). Males predominated, with a male-to-female ratio of 1.5. Consanguinity was reported in 40% of cases. The homozygous SS sickle cell diseases was predominant, accounting for 99.33%. Hand-foot syndrome was the most frequent presenting symptom, occurring in 32.67% of cases. Acute hemolytic anemia was the most frequent acute complication, occurring in 95.33% of cases. Anemia was severe in 39.33% of cases. All patients received at least one therapeutic education session. Treatment was primarily preventive, focusing on avoiding the triggering factor. <bold>Conclusion:</bold> Sickle cell disease remains a public health problem in Niger and requires improved diagnostic and therapeutic resources.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated" xml:lang="en">
        <kwd>Sickle Cell Disease</kwd>
        <kwd>CSME</kwd>
        <kwd>Agadez</kwd>
        <kwd>Niger</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>Sickle cell disease is a hemolytic anemia that causes red blood cells to sickle, leading to biochemical disturbances and varied clinical manifestations depending on age and the type of major sickle cell syndrome [<xref ref-type="bibr" rid="B1">1</xref>]. In Africa, 150,000 to 300,000 children are born with sickle cell disease each year, of whom 60% to 80% die before the age of five due to inadequate management [<xref ref-type="bibr" rid="B2">2</xref>]. Sickle cell disease represents a major public health issue in Niger due to its high prevalence, estimated at 4.2% [<xref ref-type="bibr" rid="B3">3</xref>]. It is often discovered in the context of infections, hemolysis, or vaso-occlusive crises [<xref ref-type="bibr" rid="B4">4</xref>]. Its course is marked by complications that can be acute or chronic [<xref ref-type="bibr" rid="B5">5</xref>]. Treatment has been revolutionized by hydroxyurea [<xref ref-type="bibr" rid="B6">6</xref>]. The lack of data on this condition in the Agadez region motivated this study at the Mother and Child Health Center in this region, aiming to investigate the epidemiological, diagnostic, and therapeutic aspects of major sickle cell syndromes at this center.</p>
    </sec>
    <sec id="sec2">
      <title>2. Materials and Methods</title>
      <p>Study Type and Sample </p>
      <p>This was a retrospective, descriptive study conducted from February 1, 2025, to July 31, 2025.</p>
      <p>Inclusion Criteria </p>
      <p>All sickle cell patients, regardless of age or sex, diagnosed via hemoglobin electrophoresis and followed at the Zinder Mother and Child Health Center, who provided consent. </p>
      <p>Diagnostic and Therapeutic Methods</p>
      <p>Sickle cell disease was diagnosed based on clinical suspicion, abnormal blood count findings, or systematic screening. Our diagnoses were confirmed by hemoglobin electrophoresis at alkaline Ph. Follow-up and management of sickle cell patients were carried out by two pediatricians and general practitioners. Diagnostic and therapeutic costs were borne by the patients, regardless of the number or type of complications. This study was conducted within this context.</p>
      <p>Statistical Analysis</p>
      <p>The collected information included age, sex, sociodemographic data, clinical manifestations, and diagnostic and therapeutic approaches. Data were analyzed using Epi Info software version 7.2.6.0. Pearson’s chi-squared test was used to examine relationships between qualitative variables. The test was considered significant if the p-value was &lt;0.05.</p>
      <p>Study Limitations</p>
      <p>The extremely low socioeconomic status of parents resulted in the non-performance of certain follow-up tests and the unavailability of specific therapeutic agents in the Agadez region.</p>
    </sec>
    <sec id="sec3">
      <title>3. Results (Table 1)</title>
      <sec id="sec3dot1">
        <title>3.1. Sociodemographic Data</title>
        <p><bold>Frequency</bold></p>
        <p><bold>Table 1</bold><bold>.</bold>Recapitulative results.</p>
        <table-wrap id="tbl1">
          <label>Table 1</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Variables</bold>
                </td>
                <td>
                </td>
                <td>
                  <bold>Number</bold>
                </td>
                <td>
                  <bold>Percentage</bold>
                  <bold>(%)</bold>
                </td>
              </tr>
              <tr>
                <td rowspan="2">Gender</td>
                <td>Male</td>
                <td>90</td>
                <td>60</td>
              </tr>
              <tr>
                <td>Female</td>
                <td>60</td>
                <td>40</td>
              </tr>
              <tr>
                <td rowspan="4">Age (months)</td>
                <td>0 to 24</td>
                <td>33</td>
                <td>22</td>
              </tr>
              <tr>
                <td>24 to 60</td>
                <td>51</td>
                <td>34</td>
              </tr>
              <tr>
                <td>60 to 120</td>
                <td>37</td>
                <td>24.6</td>
              </tr>
              <tr>
                <td>Above 120</td>
                <td>29</td>
                <td>19.4</td>
              </tr>
              <tr>
                <td rowspan="2">Phenotype</td>
                <td>SS</td>
                <td>149</td>
                <td>99.33</td>
              </tr>
              <tr>
                <td>SC</td>
                <td>1</td>
                <td>0.67</td>
              </tr>
              <tr>
                <td rowspan="6">Discovery Circumstance</td>
                <td>Hand-foot syndrome</td>
                <td>49</td>
                <td>32.67</td>
              </tr>
              <tr>
                <td>Sucking</td>
                <td>46</td>
                <td>30.67</td>
              </tr>
              <tr>
                <td>CVC</td>
                <td>41</td>
                <td>27.33</td>
              </tr>
              <tr>
                <td>Fever</td>
                <td>33</td>
                <td>23.33</td>
              </tr>
              <tr>
                <td>Systematic</td>
                <td>15</td>
                <td>10</td>
              </tr>
              <tr>
                <td>Jaundice</td>
                <td>11</td>
                <td>7.33</td>
              </tr>
              <tr>
                <td rowspan="5">Acute Complications</td>
                <td>Hemolysis</td>
                <td>143</td>
                <td>95.33</td>
              </tr>
              <tr>
                <td>Infection</td>
                <td>119</td>
                <td>79.33</td>
              </tr>
              <tr>
                <td>CVC</td>
                <td>109</td>
                <td>70.33</td>
              </tr>
              <tr>
                <td>Stroke</td>
                <td>6</td>
                <td>4.00</td>
              </tr>
              <tr>
                <td>STA</td>
                <td>3</td>
                <td>2.00</td>
              </tr>
              <tr>
                <td rowspan="3">Chronic Complications</td>
                <td>Osteonecrosis</td>
                <td>0</td>
                <td>-</td>
              </tr>
              <tr>
                <td>Retinopathy</td>
                <td>0</td>
                <td>-</td>
              </tr>
              <tr>
                <td>Cardiac Complications</td>
                <td>0</td>
                <td>-</td>
              </tr>
              <tr>
                <td rowspan="3">Hemoglobin Level</td>
                <td>≤6</td>
                <td>68</td>
                <td>45.33</td>
              </tr>
              <tr>
                <td>6 to 9</td>
                <td>59</td>
                <td>39.33</td>
              </tr>
              <tr>
                <td>≥10</td>
                <td>14</td>
                <td>9.33</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>During the study period, 150 cases of sickle cell syndrome were identified among 2570 patients, representing a frequency of 5.81%. Among these, 99.33% (n = 149) were homozygous SS and 0.67% (n = 1) were SC.</p>
        <p><bold>Age and Sex</bold></p>
        <p>Male patients were predominant at 60% (n = 90), while female patients accounted for 40% (n = 60), resulting in a male-to-female sex ratio of 1.5. The majority of patients fell within the age group of 24 to 60 months, representing 34% (n = 51). The mean age was 63.15 months, with extremes ranging from 2 months to 192 months.</p>
        <p><bold>Geographic Origin and Occupation</bold></p>
        <p>Most patients resided in the Urban Commune of Agadez, accounting for 80.67% (n = 121) of cases. The majority of fathers of sickle cell children were unschooled, representing 53.34% (n = 80), with most of them being merchants (53.34%, n = 80). Mothers were unschooled in 82.67% (n = 124) of cases, with the majority being homemakers (82.67%, n = 124).</p>
        <p><bold>Personal History</bold></p>
        <p>First and second consanguinity was observed in 40% (n = 60) of cases. More than half of the patients had received one to five blood transfusions, accounting for 61.33% (n = 92) of cases. Additionally, 49.33% (n = 74) of patients had up-to-date EPI vaccination status</p>
      </sec>
      <sec id="sec3dot2">
        <title>3.2. Clinical Data</title>
        <p>The majority of sickle cell syndromes were diagnosed before 24 months of age in 67.33% (n = 101) of cases, with a mean age at diagnosis of 18.33 months. Hand-foot syndrome (<xref ref-type="fig" rid="fig1">Figure 1</xref>) was the most common presenting feature, observed in 32.67% (n = 49) of cases.</p>
        <fig id="fig1">
          <label>Figure 1</label>
          <graphic xlink:href="https://html.scirp.org/file/2030366-rId13.jpeg?20260323021118" />
        </fig>
        <p><bold>Figure 1.</bold> Hand-foot syndrome.</p>
        <p>Followed by pale skin and mucous membranes in 30.67% (n = 46) (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p>
        <fig id="fig2">
          <label>Figure 2</label>
          <graphic xlink:href="https://html.scirp.org/file/2030366-rId14.jpeg?20260323021118" />
        </fig>
        <p><bold>Figure 2.</bold> Pale skin and mucous membranes.</p>
        <p>Vaso-occlusive crises in 27.33% (n = 41), fever in 23.33% (n = 35), and jaundice in 7.33% (n = 11) of cases (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p>
        <fig id="fig3">
          <label>Figure 3</label>
          <graphic xlink:href="https://html.scirp.org/file/2030366-rId15.jpeg?20260323021118" />
        </fig>
        <p><bold>Figure 3.</bold> Jaundice.</p>
        <p>Acute complications were dominated by acute drop in hemoglobin levels in 95.33% (n = 143) of cases, followed by infections in 79.33% (n = 119) and bone vaso-occlusive crises in 64.67% (n = 97). No chronic complications were recorded.</p>
      </sec>
      <sec id="sec3dot3">
        <title>3.3. Paraclinical Data</title>
        <p>The majority of sickle cell syndromes, 99.33% (n = 149), were homozygous SS, while 0.67% (n = 1) were SC. Most patients had hemoglobin levels between 6 and 9 g/dL in 39.33% (n = 59) of cases. The anemia was normochromic normocytic in 36% (n = 54) of cases. Severe anemia (hemoglobin ≤ 6 g/dL) was observed in 45.33% (n = 68) of patients. Blood group O Rh-positive was the most common, accounting for 36% (n = 54) of cases.</p>
      </sec>
      <sec id="sec3dot4">
        <title>3.4. Therapeutic Data</title>
        <p>All the children’s parents received therapeutic education, representing 100% of cases. Patients who were regularly followed up accounted for 90% (n = 135) of cases. Children under 5 years of age were systematically placed on penicillin V.</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>4. Discussion</title>
      <sec id="sec4dot1">
        <title>4.1. Epidemiological Data</title>
        <p>During the study period, 150 cases of sickle cell syndrome were identified among 2570 patients, representing a frequency of 5.81%. Djibrilla-Almoustapha A <italic>et al.</italic> in Niger (Diffa in 2024 and Dosso in 2025) reported frequencies of 4.88% and 1.08%, respectively [<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B8">8</xref>]. Among the cases, 99.33% were homozygous SS. Cissouma A <italic>et al.</italic> in Mali reported a frequency of 57% for the SS form [<xref ref-type="bibr" rid="B9">9</xref>]. The majority of patients fell within the age group of 24 to 60 months, accounting for 34% (n = 51). The mean age was 63.15 months, with extremes ranging from 2 months to 192 months. Ngolet LO <italic>et al.</italic> in Brazzaville, Mali, reported a mean age of 26.04 years [<xref ref-type="bibr" rid="B10">10</xref>]. Male patients were predominant at 60%, with a sex ratio of 1.5. Sonia Douamba <italic>et al.</italic> in Burkina Faso in 2017 reported 51.9% in favor of females [<xref ref-type="bibr" rid="B11">11</xref>]. Djibrilla-Almoustapha A <italic>et al.</italic> in Niger in 2021 found a male predominance with a sex ratio of 1.3 [<xref ref-type="bibr" rid="B12">12</xref>]. This difference is likely due to chance, as sickle cell disease is an autosomal recessive disorder. The majority of fathers of sickle cell children were unschooled (53.34%), and merchants accounted for 53.34% of cases. Mothers were unschooled in 82.67% of cases, with the majority being homemakers (82.67%). Elhadji-Chefou M <italic>et al.</italic> in Niger (Maradi) in 2024 reported similar findings [<xref ref-type="bibr" rid="B13">13</xref>]. These factors may impact the quality of care. Consanguinity was observed in 40% of cases. Diallo D in Mali in 2016 reported 32.8% of cases [<xref ref-type="bibr" rid="B14">14</xref>]. However, this result is lower than that of Nehoulne G in Chad in 2003, who reported 52% of cases [<xref ref-type="bibr" rid="B15">15</xref>].</p>
      </sec>
      <sec id="sec4dot2">
        <title>4.2. Clinical Data</title>
        <p>The majority of sickle cell syndromes were diagnosed before 24 months of age in 67.33% of cases, with a mean age at diagnosis of 18.33 months. In Niger in 2024, Abba Kaka HY <italic>et al.</italic> (2025) and Inoussa BD <italic>et al.</italic> (2022) reported similar findings [<xref ref-type="bibr" rid="B16">16</xref>][<xref ref-type="bibr" rid="B17">17</xref>]. Hand-foot syndrome was the most common presenting feature, observed in 32.67% of cases. Djibrilla-Almoustapha A <italic>et al.</italic> in Niger (Diffa) in 2024 reported similar results [<xref ref-type="bibr" rid="B7">7</xref>]. Acute complications were dominated by acute drops in hemoglobin levels (95.33%), followed by infections (79.33%). Diarra Y <italic>et al.</italic> in Burkina Faso reported a predominance of infectious complications [<xref ref-type="bibr" rid="B18">18</xref>].</p>
      </sec>
      <sec id="sec4dot3">
        <title>4.3. Paraclinical Data</title>
        <p>Most patients had hemoglobin levels between 6 and 9 g/dL (39.33%). The anemia was normochromic normocytic in 36% of cases. Severe anemia was observed in 45.33% (n = 68) of patients. Djibrilla-Almoustapha A <italic>et al.</italic> in Niger (Diffa and Dosso) reported similar findings [<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B8">8</xref>].</p>
      </sec>
      <sec id="sec4dot4">
        <title>4.4. Therapeutic Data</title>
        <p>All patients received therapeutic education (100%). This is an important step in the management of sickle cell disease, aimed at preventing significant complications. Patients who were regularly followed up accounted for 90% of cases. Diarra Y in Burkina Faso reported 80% of cases with regular follow-up [<xref ref-type="bibr" rid="B18">18</xref>].</p>
        <p>Of the patients, 49.33% (n = 74) had up-to-date EPI vaccination status. Sonia Douamba <italic>et al.</italic> in Burkina Faso reported 81.2% [<xref ref-type="bibr" rid="B11">11</xref>]. This low vaccination coverage rate may be linked to purchasing power on one hand and/or irregular follow-up on the other, both associated with low educational levels.</p>
      </sec>
    </sec>
    <sec id="sec5">
      <title>5. Conclusion</title>
      <p>Sickle cell disease is a genetic condition that presents numerous diagnostic and preventive challenges. It remains a public health issue in Niger.</p>
    </sec>
    <sec id="sec6">
      <title>Ethical Aspects</title>
      <p>This publication complied with ethical and professional standards, in particular the protection of patient identity and their approval regarding the use of images for educational purposes. </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Renaudier, P. (2014) Physiopathology of Sickle Cell Disease. <italic>Transfusion</italic><italic>Clinique</italic><italic>et</italic><italic>Biologique</italic>, 21, 178-181. https://doi.org/10.1016/j.tracli.2014.08.139 <pub-id pub-id-type="doi">10.1016/j.tracli.2014.08.139</pub-id><pub-id pub-id-type="pmid">25282490</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tracli.2014.08.139">https://doi.org/10.1016/j.tracli.2014.08.139</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Renaudier, P.</string-name>
            </person-group>
            <year>2014</year>
            <article-title>Physiopathology of Sickle Cell Disease</article-title>
            <source>Transfusion Clinique et Biologique</source>
            <volume>21</volume>
            <pub-id pub-id-type="doi">10.1016/j.tracli.2014.08.139</pub-id>
            <pub-id pub-id-type="pmid">25282490</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Diallo, D.A. (2008) Sickle Cell Disease in Africa: Challenges and Strategies for Improving Survival and Quality of Life of Patients. <italic>Bulletin de</italic><italic>l</italic>’ <italic>Académie</italic><italic>Nationale de</italic><italic>Médecine</italic>, 192, 1361-1373.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Diallo, D.A.</string-name>
            </person-group>
            <year>2008</year>
            <article-title>Sickle Cell Disease in Africa: Challenges and Strategies for Improving Survival and Quality of Life of Patients</article-title>
            <source>Bulletin de l’Académie Nationale de Médecine</source>
            <volume>192</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <citation-alternatives>
          <mixed-citation publication-type="book">Ministry of Public Health, Niger (2009) Guide to the Management of Sickle Cell Disease in Niger. Niamey. https://health.gov.ng/wp-content/uploads/2025/06/SCD-Guideline-Final-2nd-Edition.pdf</mixed-citation>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <string-name>Health, N</string-name>
            </person-group>
            <year>2009</year>
            <article-title>Guide to the Management of Sickle Cell Disease in Niger</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Mondé, A.A., Kouamé-Koutouan, A., Tiahou, G.G., Camara, C.M., Yapo, A.A., Djessou, S.P., <italic>et al</italic>. (2010) Lipidoprotein Profile, Isotopic Profile, and Atherogenic Risk in Sickle Cell Disease in Côte d’Ivoire. <italic>Médecine</italic><italic>Nucléaire</italic>, 34, e17-e21. https://doi.org/10.1016/j.mednuc.2010.07.015 <pub-id pub-id-type="doi">10.1016/j.mednuc.2010.07.015</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.mednuc.2010.07.015">https://doi.org/10.1016/j.mednuc.2010.07.015</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Koutouan, A.</string-name>
              <string-name>Tiahou, G.G.</string-name>
              <string-name>Camara, C.M.</string-name>
              <string-name>Yapo, A.A.</string-name>
              <string-name>Djessou, S.P.</string-name>
              <string-name>Profile, I</string-name>
            </person-group>
            <year>2010</year>
            <article-title>Lipidoprotein Profile, Isotopic Profile, and Atherogenic Risk in Sickle Cell Disease in Côte d’Ivoire</article-title>
            <source>Médecine Nucléaire</source>
            <volume>34</volume>
            <pub-id pub-id-type="doi">10.1016/j.mednuc.2010.07.015</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Ngolet, L.O., Ova, J.D., Ntsiba, H., <italic>et al</italic>. (2017) Chronic Complications in Adult Sickle Cell Patients in Brazzaville. <italic>Health Sciences and Disease</italic><italic>s</italic>, 18, 56-59. https://www.hsd-fmsb.org/index.php/hsd/article/view/812</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Ngolet, L.O.</string-name>
              <string-name>Ova, J.D.</string-name>
              <string-name>Ntsiba, H.</string-name>
            </person-group>
            <year>2017</year>
            <article-title>Chronic Complications in Adult Sickle Cell Patients in Brazzaville</article-title>
            <source>Health Sciences and Diseases</source>
            <volume>18</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Diop, S., Tsshilo, L., Nnodu, O., Mumba, N. and Abdoullahi, S. (2023) Mortality and Causes of Death among Sickle Cell Patients in Sub-Saharan Africa: A Multi-Centre Study. <italic>The Lancet</italic><italic>Haematology</italic>, 10, e270-e280.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Diop, S.</string-name>
              <string-name>Tsshilo, L.</string-name>
              <string-name>Nnodu, O.</string-name>
              <string-name>Mumba, N.</string-name>
              <string-name>Abdoullahi, S.</string-name>
            </person-group>
            <year>2023</year>
            <article-title>Mortality and Causes of Death among Sickle Cell Patients in Sub-Saharan Africa: A Multi-Centre Study</article-title>
            <source>The Lancet Haematology</source>
            <volume>10</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Djibrilla-Almoustapha, A., Malam-Abdou, B., Mamadou-Malam, B.A., Adamou-Chaibou, O., Elhadji-Chefou, M. and Maman-Brah, M. (2024) Major Sickle Cell Syndromes in Children in Diffa (Niger): Epidemiological, Diagnostic, and Therapeutic Aspects. <italic>Health Sciences and Diseases</italic>, 25, 43-47.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Djibrilla-Almoustapha, A.</string-name>
              <string-name>Malam-Abdou, B.</string-name>
              <string-name>Mamadou-Malam, B.A.</string-name>
              <string-name>Adamou-Chaibou, O.</string-name>
              <string-name>Elhadji-Chefou, M.</string-name>
              <string-name>Maman-Brah, M.</string-name>
              <string-name>Epidemiological, D</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Major Sickle Cell Syndromes in Children in Diffa (Niger): Epidemiological, Diagnostic, and Therapeutic Aspects</article-title>
            <source>Health Sciences and Diseases</source>
            <volume>25</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Djibrilla-Almoustapha, A., Ibrahim-Dourfaye, K., Adamou-Chaibou, O., Elhadji-Chefou, M., Maman-Brah, M., Aboubacar, S., <italic>et al</italic>. (2025) Les syndromes drépanocytaires majeurs chez l’enfant à Dosso (Niger): Aspects épidémiologiques, diagnostiques et thérapeutiques. <italic>Journal</italic><italic>Africain</italic><italic>des</italic><italic>Cas</italic><italic>Cliniques</italic><italic>et</italic><italic>Revues</italic>, 9, 208-214. https://doi.org/10.70065/2593.jaccrafri.016l012308 <pub-id pub-id-type="doi">10.70065/2593.jaccrafri.016l012308</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.70065/2593.jaccrafri.016l012308">https://doi.org/10.70065/2593.jaccrafri.016l012308</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Djibrilla-Almoustapha, A.</string-name>
              <string-name>Ibrahim-Dourfaye, K.</string-name>
              <string-name>Adamou-Chaibou, O.</string-name>
              <string-name>Elhadji-Chefou, M.</string-name>
              <string-name>Maman-Brah, M.</string-name>
              <string-name>Aboubacar, S.</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Les syndromes drépanocytaires majeurs chez l’enfant à Dosso (Niger): Aspects épidémiologiques, diagnostiques et thérapeutiques</article-title>
            <source>Journal Africain des Cas Cliniques et Revues</source>
            <volume>9</volume>
            <pub-id pub-id-type="doi">10.70065/2593.jaccrafri.016l012308</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Cissouma, A., Traoré, M., Kassogué, D., Poma, H., Sangaré, A. and Traoré-Kissima, A. (2021) Epidemiological and Clinical Aspects of Sickle Cell Disease in Children at Sikasso Hospital. <italic>Health Sciences and Disease</italic>, 22, 57-60. https://www.hsd-fmsb.org/index.php/hsd/article/view/2959.</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Cissouma, A.</string-name>
              <string-name>Poma, H.</string-name>
              <string-name>Kissima, A.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Epidemiological and Clinical Aspects of Sickle Cell Disease in Children at Sikasso Hospital</article-title>
            <source>Health Sciences and Disease</source>
            <volume>22</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Ngolet, L.O., Bayonne, S. and Elira Dokekias, A. (2017) Leg Ulcers in Sickle Cell Patients in Brazzaville. <italic>Health Sciences and Disease</italic>, 18, 98-101. https://www.hsd-fmsb.org/index.php/hsd/article/download/944/pdf_497/2745</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Ngolet, L.O.</string-name>
              <string-name>Bayonne, S.</string-name>
              <string-name>Dokekias, A.</string-name>
            </person-group>
            <year>2017</year>
            <article-title>Leg Ulcers in Sickle Cell Patients in Brazzaville</article-title>
            <source>Health Sciences and Disease</source>
            <volume>18</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Douamba, S., Nagalo, K., Tamini, L., Traoré, I., Kam, M., Kouéta, F., <italic>et al</italic>. (2017) Major Sickle Cell Syndromes and Associated Infections in Children in Burkina Faso. <italic>Pan African Medical Journal</italic>, 26, Article No. 65. https://www.panafrican-med-journal.com/content/article/26/7/full/</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Douamba, S.</string-name>
              <string-name>Nagalo, K.</string-name>
              <string-name>Tamini, L.</string-name>
              <string-name>Kam, M.</string-name>
            </person-group>
            <year>2017</year>
            <article-title>Major Sickle Cell Syndromes and Associated Infections in Children in Burkina Faso</article-title>
            <source>Pan African Medical Journal</source>
            <volume>26</volume>
            <elocation-id>No</elocation-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Almoustapha, A.D., Brah, M.M., <italic>et al</italic>. (2021) Observation of Causes of Death from Sickle Cell Anemia in Niger. <italic>Annals</italic><italic>of</italic><italic>Hematology</italic><italic>&amp;</italic><italic>Oncology</italic>, 8, Article No. 1329. https://doi.org/10.26420/annhematoloncol.2021.1329 <pub-id pub-id-type="doi">10.26420/annhematoloncol.2021.1329</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.26420/annhematoloncol.2021.1329">https://doi.org/10.26420/annhematoloncol.2021.1329</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Almoustapha, A.D.</string-name>
              <string-name>Brah, M.M.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Observation of Causes of Death from Sickle Cell Anemia in Niger</article-title>
            <source>Annals of Hematology &amp; Oncology</source>
            <volume>8</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.26420/annhematoloncol.2021.1329</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Elhadji-Chefou, M., Malam-Abdou, B., Djibrilla-Almoustapha, A., Maman Brah, M., Mahamadou Ali, D. and Kimso, O. (2024) Major Sickle Cell Syndromes in Maradi, Niger: Epidemiological, Clinical, Biological and Therapeutic Aspects. <italic>Open Journal of Blood Diseases</italic>, 6, 34-45. https://www.scirp.org/journal/paperinformation?paperid=137149</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Elhadji-Chefou, M.</string-name>
              <string-name>Malam-Abdou, B.</string-name>
              <string-name>Djibrilla-Almoustapha, A.</string-name>
              <string-name>Brah, M.</string-name>
              <string-name>Ali, D.</string-name>
              <string-name>Kimso, O.</string-name>
              <string-name>Maradi, N</string-name>
              <string-name>Epidemiological, C</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Major Sickle Cell Syndromes in Maradi, Niger: Epidemiological, Clinical, Biological and Therapeutic Aspects</article-title>
            <source>Open Journal of Blood Diseases</source>
            <volume>6</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="web">DDiakité, A.A., Dembélé, A., Cissé, M.E., <italic>et al.</italic> () Bone and Joint Complications of Sickle Cell Disease in the Department of Pediatrics of CHU Gabriel Touré. <italic>Health Sciences and Disease</italic>, 20, 76-81. https://www.hsd-fmsb.org/index.php/hsd/article/view/1474</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <citation-alternatives>
          <mixed-citation publication-type="thesis">Nehoulne, G. (2003) Sickle Cell Hemoglobinopathies: Epidemiological and Clinical Aspects and Exposure Factors in the Pediatric Department of the National Reference General Hospital of N’Djamena. Doctoral Thesis in Medicine (MD), Faculty of Human Health Sciences. https://www.scirp.org/(S(351jmbntvnsjtlaadkozje))/reference/referencespapers?referenceid=1868256</mixed-citation>
          <element-citation publication-type="thesis">
            <person-group person-group-type="author">
              <string-name>Nehoulne, G.</string-name>
            </person-group>
            <year>2003</year>
            <article-title>Sickle Cell Hemoglobinopathies: Epidemiological and Clinical Aspects and Exposure Factors in the Pediatric Department of the National Reference General Hospital of N’Djamena</article-title>
            <source>Doctoral Thesis in Medicine (MD)</source>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Abba Kaka, H.Y., Souley, C., Nouhou Diori, A., Cisse Mamadou, I., Youssoufou, S.A. and Laminou, L. (2025) Prevalence of Ocular Complications in Sickle Cell Disease in Niamey: A Prospective Cross-Sectional Study of 100 Patients. <italic>Health Sciences and Disease</italic>, 26, 54-59. https://www.hsd-fmsb.org/index.php/hsd/article/view/7057</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Kaka, H.Y.</string-name>
              <string-name>Souley, C.</string-name>
              <string-name>Diori, A.</string-name>
              <string-name>Mamadou, I.</string-name>
              <string-name>Youssoufou, S.A.</string-name>
              <string-name>Laminou, L.</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Prevalence of Ocular Complications in Sickle Cell Disease in Niamey: A Prospective Cross-Sectional Study of 100 Patients</article-title>
            <source>Health Sciences and Disease</source>
            <volume>26</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Inoussa, B.D., Malika, M.L.N., Matallah, S.M., Marie, O., Habiba, T.M.S., Eric, O.A., <italic>et al</italic>. (2022) Ultrasound Aspects of Abdominal Manifestations of Sickle Cell Disease. <italic>Health Sciences and Disease</italic>, 23, 95-98. https://www.hsd-fmsb.org/index.php/hsd/article/view/3332</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Inoussa, B.D.</string-name>
              <string-name>Malika, M.L.N.</string-name>
              <string-name>Matallah, S.M.</string-name>
              <string-name>Marie, O.</string-name>
              <string-name>Habiba, T.M.S.</string-name>
              <string-name>Eric, O.A.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Ultrasound Aspects of Abdominal Manifestations of Sickle Cell Disease</article-title>
            <source>Health Sciences and Disease</source>
            <volume>23</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Diarra, Y., <italic>et al</italic>. (2008) Management of Sickle Cell Disease in Pediatric Settings: Experience from the Charles de Gaulle Pediatric University Hospital in Ouagadougou (Burkina Faso). <italic>Cahiers Santé</italic>, 18, 7-12. https://pubmed.ncbi.nlm.nih.gov/19188129/</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Diarra, Y.</string-name>
            </person-group>
            <year>2008</year>
            <article-title>Management of Sickle Cell Disease in Pediatric Settings: Experience from the Charles de Gaulle Pediatric University Hospital in Ouagadougou (Burkina Faso)</article-title>
            <source>Cahiers Santé</source>
            <volume>18</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
    </ref-list>
  </back>
</article>